Institutional investors purchased a net $3.9 million shares of PCRX during the quarter ended June 2014 and now own 105.27% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EAGLE ASSET MANAGEMENT, INC. Bought 17.9 Thousand shares of Pacira Pharmaceuticals In...